T1	Age 25 29	Aged
E1	Age:T1
T2	Eq-Comparison 30 47	at least 18 years
E2	Eq-Comparison:T2 Operator:T104 Value:T105 Temporal-Unit:T106
T3	Modifier 54 68	Histologically
E3	Modifier:T3
T4	Or 69 71	or
E4	Or:T4
T5	Procedure 72 85	cytologically
E5	Procedure:T5
T6	Condition 106 111	NSCLC
E6	Condition:T6 Name:T108
T7	Modifier 120 136	locally advanced
E7	Modifier:T7
T8	Or 137 139	or
E8	Or:T8
T9	Modifier 140 150	metastatic
E9	Modifier:T9
T10	Procedure 157 169	Radiological
E10	Procedure:T10
T11	Condition 187 206	disease progression
E11	Condition:T11 Name:T110
T12	Temporal-Connection 207 212	while
E12	Temporal-Connection:T12
A1	Temporal-Connection-Type-Value E12 during
T13	Eq-Comparison 218 226	previous
E13	Eq-Comparison:T13 Temporal-Period:T111
T14	Procedure 238 247	treatment
E14	Procedure:T14
T15	Modifier 256 261	first
E15	Modifier:T15
T16	Or 262 264	or
E16	Or:T16
T17	Modifier 265 282	second generation
E17	Modifier:T17
T18	Drug 286 294	EGFR TKI
E18	Drug:T18 Name:T113
T19	Drug 300 309	gefitinib
E19	Drug:T19 Name:T114
T20	Or 310 312	or
E20	Or:T20
T21	Drug 313 322	erlotinib
E21	Drug:T21 Name:T115
T22	Condition 369 397	tumour T790M mutation status
E22	Condition:T22 Name:T116
T23	Temporal-Connection 419 424	after
E23	Temporal-Connection:T23
A2	Temporal-Connection-Type-Value E23 after
T24	Condition 425 444	disease progression
E24	Condition:T24 Name:T118
T25	Eq-Comparison 452 457	prior
E25	Eq-Comparison:T25 Temporal-Period:T119
T26	Drug 458 466	EGFR TKI
E26	Drug:T26
T27	Observation 473 526	Eastern cooperative oncology group performance status
E27	Observation:T27 Name:T120
T28	Observation 528 532	ECOG
E28	Observation:T28 Name:T121
T29	Eq-Comparison 540 542	0-
E29	Eq-Comparison:T29 Value:T122 Operator:T123
T30	Observation 560 575	life expectancy
E30	Observation:T30 Name:T126
T31	Eq-Comparison 579 587	12 weeks
E31	Eq-Comparison:T31 Value:T127 Temporal-Unit:T128
T32	Eq-Comparison 594 606	At least one
E32	Eq-Comparison:T32 Operator:T129 Value:T130
T33	Condition 607 613	lesion
E33	Condition:T33 Name:T131
T34	Negation 615 618	not
E34	Negation:T34
T35	Eq-Comparison 619 629	previously
E35	Eq-Comparison:T35 Temporal-Period:T132
T36	Procedure 630 640	irradiated
E36	Procedure:T36
T37	Temporal-Connection 641 647	during
E37	Temporal-Connection:T37
A3	Temporal-Connection-Type-Value E37 during
T38	Study 652 657	study
E38	Study:T38
T39	Study 658 667	screening
E39	Study:T39
T40	Assertion 681 687	can be
E40	Assertion:T40
A4	Assertion-Type-Value E40 hypothetical
T41	Temporal-Connection 708 710	at
E41	Temporal-Connection:T41
A5	Temporal-Connection-Type-Value E41 during
T42	Study 711 719	baseline
E42	Study:T42
T43	Assertion 750 758	Agree to
E43	Assertion:T43
A6	Assertion-Type-Value E43 hypothetical
T44	Drug 794 807	contraceptive
E44	Drug:T44
T45	Temporal-Connection 817 823	during
E45	Temporal-Connection:T45
A7	Temporal-Connection-Type-Value E45 during
T46	Study 835 840	study
E46	Study:T46
T47	And 848 851	and
E47	And:T47
T48	Eq-Comparison 852 866	within 6 weeks
E48	Eq-Comparison:T48 Operator:T133 Value:T134 Temporal-Unit:T135
T49	Temporal-Connection 867 872	after
E49	Temporal-Connection:T49
A8	Temporal-Connection-Type-Value E49 after
T50	Eq-Comparison 877 881	last
E50	Eq-Comparison:T50 Temporal-Period:T136
T51	Temporal-Connection 887 890	pre
E51	Temporal-Connection:T51
A9	Temporal-Connection-Type-Value E51 before
T52	Condition 891 901	menopausal
E52	Condition:T52
T53	Assertion 938 945	need to
E53	Assertion:T53
A10	Assertion-Type-Value E53 hypothetical
T54	Condition 954 963	pregnancy
E54	Condition:T54 Name:T139
T55	Observation 977 991	pregnancy test
E55	Observation:T55 Name:T141
T56	Or 993 996	and
E56	Or:T56
T57	Negation 1000 1003	non
E57	Negation:T57
T58	Condition 1004 1013	lactation
E58	Condition:T58 Name:T142
T59	Procedure 1047 1056	Treatment
E59	Procedure:T59
T60	Modifier 1064 1069	first
E60	Modifier:T60
T61	Or 1070 1072	or
E61	Or:T61
T62	Modifier 1073 1090	second generation
E62	Modifier:T62
T63	Drug 1094 1102	EGFR-TKI
E63	Drug:T63 Name:T143
T64	Eq-Comparison 1103 1116	within 7 days
E64	Eq-Comparison:T64 Operator:T144 Value:T145 Temporal-Unit:T146
T65	Temporal-Connection 1117 1119	of
E65	Temporal-Connection:T65
A11	Temporal-Connection-Type-Value E65 before
T66	Study 1120 1125	study
E66	Study:T66
T67	Study 1126 1131	entry
E67	Study:T67
T68	Eq-Comparison 1133 1141	previous
E68	Eq-Comparison:T68 Temporal-Period:T147
T69	Procedure 1142 1151	treatment
E69	Procedure:T69
T70	Eq-Comparison 1159 1164	third
E70	Eq-Comparison:T70
T71	Drug 1179 1187	EGFR-TKI
E71	Drug:T71 Name:T148
T72	Modifier 1194 1204	Unresolved
E72	Modifier:T72
T73	Condition 1205 1215	toxicities
E73	Condition:T73 Name:T149
T74	Eq-Comparison 1221 1226	prior
E74	Eq-Comparison:T74 Temporal-Period:T150
T75	Procedure 1227 1234	therapy
E75	Procedure:T75 Name:T151
T76	Modifier 1241 1249	Unstable
E76	Modifier:T76
T77	Condition 1250 1273	spinal cord compression
E77	Condition:T77 Name:T152
T78	Or 1273 1274	/
E78	Or:T78
T79	Modifier 1274 1279	brain
E79	Modifier:T79
T80	Condition 1280 1290	metastases
E80	Condition:T80 Name:T153
T81	Or 1303 1304	/
E81	Or:T81
T82	Modifier 1304 1316	uncontrolled
E82	Modifier:T82
T83	Modifier 1317 1325	systemic
E83	Modifier:T83
T84	Condition 1326 1334	diseases
E84	Condition:T84
T85	Modifier 1346 1358	uncontrolled
E85	Modifier:T85
T86	Condition 1359 1371	hypertension
E86	Condition:T86 Name:T156
T87	Condition 1373 1381	bleeding
E87	Condition:T87
T88	Modifier 1382 1391	diatheses
E88	Modifier:T88
T89	Or 1392 1394	or
E89	Or:T89
T90	Condition 1395 1404	infection
E90	Condition:T90 Name:T158
T91	Eq-Comparison 1411 1424	QTcF>470 msec
E91	Eq-Comparison:T91
T92	Temporal-Connection 1425 1431	during
E92	Temporal-Connection:T92
A12	Temporal-Connection-Type-Value E92 during
T93	Study 1436 1445	screening
E93	Study:T93
T94	Condition 1466 1486	respiratory diseases
E94	Condition:T94 Name:T161
T95	Condition 1495 1520	interstitial lung disease
E95	Condition:T95 Name:T162
T96	Condition 1529 1535	asthma
E96	Condition:T96 Name:T164
T97	Condition 1537 1555	pulmonary embolism
E97	Condition:T97 Name:T165
T98	Eq-Comparison 1567 1575	previous
E98	Eq-Comparison:T98 Temporal-Period:T166
T99	Procedure 1576 1585	treatment
E99	Procedure:T99
T100	Eq-Comparison 1591 1600	2 or more
E100	Eq-Comparison:T100 Value:T167 Operator:T168
T101	Procedure 1610 1622	Chemotherapy
E101	Procedure:T101 Name:T169
T102	Or 1623 1625	or
E102	Or:T102
T103	Procedure 1626 1639	immunotherapy
E103	Procedure:T103 Name:T170
T104	Eq-Operator 30 38	at least
A13	Eq-Operator-Value T104 GTEQ
T105	Eq-Value 39 41	18
T106	Eq-Temporal-Unit 42 47	years
A14	Eq-Temporal-Unit-Value T106 year
T107	Condition-Name 72 85	cytologically
T108	Condition-Name 106 111	NSCLC
T109	Condition-Name 140 150	metastatic
T110	Condition-Name 187 206	disease progression
T111	Eq-Temporal-Period 218 226	previous
A15	Eq-Temporal-Period-Value T111 past
T112	Eq-Temporal-Period 227 237	continuous
A16	Eq-Temporal-Period-Value T112 present
T113	Drug-Name 286 294	EGFR TKI
T114	Drug-Name 300 309	gefitinib
T115	Drug-Name 313 322	erlotinib
T116	Condition-Name 369 380	tumour T790
T117	Polarity 409 417	positive
A17	Polarity-Value T117 positive
T118	Condition-Name 425 444	disease progression
T119	Eq-Temporal-Period 452 457	prior
A18	Eq-Temporal-Period-Value T119 past
T120	Observation-Name 473 526	Eastern cooperative oncology group performance status
A19	Observation-Type-Value T120 clinical-score
T121	Observation-Name 528 532	ECOG
T122	Eq-Value 540 541	0
T123	Eq-Operator 541 542	-
A20	Eq-Operator-Value T123 BETWEEN
T124	Eq-Value 542 543	1
T125	Eq-Operator 552 559	minimum
A21	Eq-Operator-Value T125 GTEQ
T126	Observation-Name 560 575	life expectancy
T127	Eq-Value 579 581	12
T128	Eq-Temporal-Unit 582 587	weeks
A22	Eq-Temporal-Unit-Value T128 week
T129	Eq-Operator 594 602	At least
A23	Eq-Operator-Value T129 GTEQ
T130	Eq-Value 603 606	one
T131	Condition-Name 607 613	lesion
T132	Eq-Temporal-Period 619 629	previously
A24	Eq-Temporal-Period-Value T132 past
T133	Eq-Operator 852 858	within
A25	Eq-Operator-Value T133 LTEQ
T134	Eq-Value 859 860	6
T135	Eq-Temporal-Unit 861 866	weeks
A26	Eq-Temporal-Unit-Value T135 week
T136	Eq-Temporal-Period 877 881	last
A27	Eq-Temporal-Period-Value T136 past
T137	Condition-Name 891 911	menopausal fertility
T138	Life-Stage-And-Gender 922 928	Female
A28	Life-Stage-And-Gender-Type T138 female
T139	Condition-Name 954 963	pregnancy
T140	Polarity 968 976	negative
A29	Polarity-Value T140 negative
T141	Observation-Name 977 991	pregnancy test
A30	Observation-Type-Value T141 lab
T142	Condition-Name 1004 1013	lactation
T143	Drug-Name 1094 1102	EGFR-TKI
T144	Eq-Operator 1103 1109	within
A31	Eq-Operator-Value T144 LTEQ
T145	Eq-Value 1110 1111	7
T146	Eq-Temporal-Unit 1112 1116	days
A32	Eq-Temporal-Unit-Value T146 day
T147	Eq-Temporal-Period 1133 1141	previous
A33	Eq-Temporal-Period-Value T147 past
T148	Drug-Name 1179 1187	EGFR-TKI
T149	Condition-Name 1205 1215	toxicities
T150	Eq-Temporal-Period 1221 1226	prior
A34	Eq-Temporal-Period-Value T150 past
T151	Procedure-Name 1227 1234	therapy
T152	Condition-Name 1250 1273	spinal cord compression
T153	Condition-Name 1280 1290	metastases
T154	Severity 1297 1303	Severe
A35	Severity-Value T154 severe
T155	Condition-Name 1317 1334	systemic diseases
T156	Condition-Name 1359 1371	hypertension
T157	Condition-Name 1373 1391	bleeding diatheses
T158	Condition-Name 1395 1404	infection
T159	Condition-Name 1411 1424	QTcF>470 msec
T160	Severity 1459 1465	Severe
A36	Severity-Value T160 severe
T161	Condition-Name 1466 1486	respiratory diseases
T162	Condition-Name 1495 1520	interstitial lung disease
T163	Severity 1522 1528	severe
A37	Severity-Value T163 severe
T164	Condition-Name 1529 1535	asthma
T165	Condition-Name 1537 1555	pulmonary embolism
T166	Eq-Temporal-Period 1567 1575	previous
A38	Eq-Temporal-Period-Value T166 past
T167	Eq-Value 1591 1592	2
T168	Eq-Operator 1593 1600	or more
A39	Eq-Operator-Value T168 GTEQ
T169	Procedure-Name 1610 1622	Chemotherapy
T170	Procedure-Name 1626 1639	immunotherapy